Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer’s disease in older adults.

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

Getting a good night's sleep is a critical part of our daily biological cycle and is associated with improved brain function, ...

A research team has discovered intricate molecular mechanisms driving the RNA processing defects that lead to Huntington's disease and link HD with other neurodegenerative disorders such as ...

Mild cognitive impairment (MCI) refers to a noticeable decline in cognitive abilities, such as memory and thinking, that is more severe than expected for a person's age but not severe enough to ...

Posdinemab is an investigational monoclonal antibody that targets the mid-domain of Alzheimer's disease-specific ...

For many years, platinum-based chemotherapy has been one of the mainstays for advanced testicular cancer. Painful peripheral neuropathy, especially in the hands and feet, is a common side effect.

Discover a groundbreaking study that may help detect Alzheimer's in its early stages. Learn about the link between blood molecules and cognitive symptoms.

Delve into the challenges Black Americans face with Alzheimer’s and the urgent need for better prevention, care, and ...

POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...